In mouse models of highfat dietinduced liver steatosis, it significantly inhibits hepatic NNMT activity, reduces NAM methylation, increases NAD+ and SAM levels, enhances mitochondrial fatty acid oxidation, reduces hepatic triglyceride and lipid accumulation, lowers lipotoxicity markers (e.g., malondialdehyde, transaminases), improves hepatocellular injury, and reverses steatosis
BPC 157 excels in muscle and tendon repair, while TB-500 focuses on reducing inflammation and enhancing mobility
What this means, is that using antacids on a long-term basis can result in malabsorption of vitamin B12
When administered into the brain circulation and cerebrospinal fluid of mice, DSIP showed a significant, dose-dependent reduction in pain response in the tail-pinch and hot-plate tests
You're injecting inactive compound
What side effects have you seen with peptides